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Presbyopic Corneal TreatmentsMICHIEL H.A. LUGER, COLM MCALINDEN, PHILIP J. BUCKHURST, JAMES S. WOLFFSOHN,
SHWETABH VERMA, AND SAMUEL ARBA MOSQUERA PURPOSE: To evaluate distance and near image quality
after hybrid bi-aspheric multifocal central presbyLASIK
treatments.
 DESIGN: Consecutive case series.
 METHODS: Sixty-four eyes of 32 patients consecutively
treated with central presbyLASIK were assessed. The
mean age of the patients was 51 ± 3 years with a mean
spherical equivalent refraction ofL1.08 ± 2.62 diopters
(D) and mean astigmatism of 0.52 ± 0.42 D. Monocular
corrected distance visual acuity (CDVA), corrected near
visual acuity (CNVA), and distance corrected near visual
acuity (DCNVA) of nondominant eyes; binocular uncor-
rected distance visual acuity (UDVA); uncorrected in-
termediate visual acuity (UIVA); distance corrected
intermediate visual acuity (DCIVA); and uncorrected
near visual acuity (UNVA) were assessed pre- and post-
operatively. Subjective quality of vision and near vision
was assessed using the 10-item Rasch-scaled Quality of
Vision and Near Activity Visual Questionnaire, respec-
tively.
 RESULTS: At 1 year postoperatively, 93% of patients
achieved 20/20 or better binocular UDVA; 90% and
97% of patients had J2 or better UNVA and UIVA,
respectively; 7% lost 2 Snellen lines of CDVA; Strehl ra-
tio reduced bywL4% ± 14%. Defocus curves revealed a
loss of half a Snellen line at best focus, with no change for
intermediate vergence (L1.25 D) and a mean gain of 2
lines for near vergence (L3 D).
 CONCLUSIONS: Presbyopic treatment using a hybrid
bi-aspheric micro-monovision ablation profile is safe and
efficacious. The postoperative outcomes indicate im-
provements in binocular vision at far, intermediate, and
near distances with improved contrast sensitivity. A
19% retreatment rate should be considered to increase
satisfaction levels, besides a 3% reversal rate. (Am J
Ophthalmol 2015;160(3):493–505.  2015 by
Elsevier Inc. All rights reserved.)r publication May 19, 2015.
man Oogzorg, Naarden, Netherlands (M.H.A.L.); Flinders
Adelaide, South Australia, Australia (C.M.); School of
essions, Plymouth University, United Kingdom (P.J.B.);
ife and Health Sciences, Aston University, Birmingham,
gdom (J.S.W.); and SCHWIND eye-tech-solutions,
, Germany (S.V., S.A.M.).
to Michiel H.A. Luger, Bergman Oogzorg, Rijksweg 69,
ederlande; e-mail: M.Luger@bergmanclinics.nl
36.00
org/10.1016/j.ajo.2015.05.021
 2015 BY ELSEVIER INC.P
RESBYOPIA IS AN AGE-RELATED CONDITION CHAR-
acterized by the gradual loss of the eye’s ability
to focus actively on nearby objects. This condition
is mainly attributed to a loss of elasticity of the crystalline
lens, accompanied by a change in the ciliary muscle
strength and lens curvature.1 Refractive surgeons have
faced challenges in effectively combining the treatment
of refractive errors and presbyopia. Surgical presbyopia
corrections have seen several developments, from the
monovision and multifocal ablation techniques to the
modern hybrid methods combining the benefits of several
techniques. Corneal inlays and intraocular lenses have
also been a popular alternative treatment for presbyopia.2
Monovision techniques3 usually involve correcting the
dominant eye for distance, as opposed to crossed monovi-
sion,4 where the dominant eye is corrected for near
vision.
Charman5 proposed that the main aim of presbyopia
treatments was to extend the binocular depth of focus
to yield adequate distance and near vision with good
retinal contrast at lower spatial frequencies. Dai6 first pro-
posed the use of rigorous methodologies to theoretically
optimize vision over the entire target range from near
to distance. Multifocal ablations are designed to achieve
these characteristics. These result in a pseudo-
accommodative cornea realized either in the form of a pe-
ripheral near zone (concentric ring for near vision)7 or in
the form of a central near zone (central disc for near
vision).8
PresbyLASIK is one such robust technique based on
traditional laser-assisted in situ keratomileusis (LASIK)
to correct the visual defect for distance while simulta-
neously reducing the near spectacle dependency in pres-
byopic patients.9,10 PresbyLASIK has been stated as a
promising technology, but lacking the level of maturity
of monovision.11 For achieving maximum patient satis-
faction, good near vision should be accompanied
with no detrimental effect in the distance vision. A
hybrid method combining micro-monovision and multi-
focal ablation could potentially achieve full range of
vision.
In this work, a hybrid bi-aspheric micro-monovision
technique is presented and the outcomes are retrospec-
tively analyzed in 64 consecutive eyes (of 32 patients)
treated using this method.493ALL RIGHTS RESERVED.
FIGURE 1. Changes in binocular uncorrected visual acuity at 1 year follow-up after treating with hybrid bi-aspheric micro-
monovision ablation profile for presbyopic corneal treatments. Myopic patients are presented in the left panels and hyperopic patients
are presented in the right panels. (Top left)Ninety-three percent of themyopic patients achieved 20/20 or better binocular uncorrected
distance visual acuity (UDVA); (Top right) 94%of hyperopic patients achieved20/20 or better binocularUDVA; (Middle left) 100%
of myopic patients achieved Jaeger level J2 or better binocular uncorrected intermediate visual acuity (UIVA); (Middle right) 94% of
hyperopic patients achieved Jaeger level J2 or better UIVA; (Bottom left) 93% of myopic patients achieved Jaeger level J2 or better
uncorrected near visual acuity (UNVA); (Bottom right) 88% of hyperopic patients achieved Jaeger level J2 or better UNVA.METHODS
 PATIENTS: This cohort study was based on a consecutive
case series of patients treated by a single surgeon
(M.H.A.L.) with the hybrid bi-aspheric micro-
monovision technique to correct presbyopia, at494 AMERICAN JOURNAL OFVisionClinics, Utrecht, Netherlands. Proper informed con-
sent was obtained from each patient, for both the treatment
and use of their de-identified clinical data for publication.
The Independent Review Board Nijmegen (IRBN) evalu-
ated the study and stated that the investigation in this
form is not subject to the Medical Research InvolvingSEPTEMBER 2015OPHTHALMOLOGY
FIGURE 2. Contrast sensitivity scores assessed preoperatively and 3 months (3M), 6 months (6M), and 1 year (1Y) after treating
with hybrid bi-aspheric micro-monovision ablation profile for presbyopic corneal treatments. The contrast sensitivity scores were
assessed with (Top) and without (Bottom) disability glare. At 3 and 6 months follow-up, the contrast sensitivity scores remained
similar to the respective preoperative scores in both tests (with and without the disability glare), but improved, respectively, at 1
year follow-up (P< .005 at all sizes). The error bars represent the upper and lower 95% confidence limits of the mean of measure-
ments, preoperatively and 1 year postoperatively.Human Subjects Act (WMO). The outcomes of perform-
ing presbyLASIK in 64 consecutive eyes (32 patients)
were retrospectively analyzed. The average age of the 32
patients (17 male and 15 female; 17 hyperopic and 15
myopic) was 51 6 3 years (range 45–55 years). The mean
preoperative spherical equivalent was 1.08 6 2.62 D
(6.75 to 2.00 D), with mean preoperative astigmatism
0.546 0.50 D (0.00–2.10 D) andmean spectacle near addi-
tion 1.75 6 0.36 D (1.00–2.50 D).VOL. 160, NO. 3 HYBRID BI-ASPHERIC MICRO-MONOTo categorize the candidate as presbyopic, the monoc-
ular corrected near visual acuity (CNVA) at 40 cm had
to be at least 2 logRAD lines better than the distance
corrected near visual acuity (DCNVA) at 40 cm in each
eye. Inclusion criteria were patients older than 45 years,
medically suitable for LASIK, presbyopic, with corrected
distance visual acuity (CDVA) no worse than 20/32 in
either eye (with at least 20/25 in the best eye), stable refrac-
tion (<0.5 D change in mean spherical equivalent) for 1495VISION PROFILES IN PRESBYOPIA
FIGURE 3. Changes in binocular distance corrected visual acuity at 1 year follow-up after treating with hybrid bi-aspheric micro-
monovision ablation profile for presbyopic corneal treatments. Myopic patients are presented in the left panels and hyperopic patients
are presented in the right panels. (Top left) At 1 year follow-up, 85% of myopic patients achieved a Jaeger level J2 or better binocular
distance corrected intermediate visual acuity (DCIVA). (Top right) At 1 year follow-up, 94% of hyperopic patients achieved a Jaeger
level J2 or better binocular DCIVA. (Bottom left) At 1 year follow-up, 57% of myopic patients achieved a Jaeger level J4 or better
binocular distance corrected near visual acuity (DCNVA). (Bottom right) At 1 year follow-up, 63% of hyperopic patients achieved a
Jaeger level J4 or better binocular DCNVA.year prior to the study, discontinued usage of contact lenses
for at least 2–4 weeks (depending on contact lens type)
prior to the preoperative evaluation, and photopic pupil
diameter smaller than 3.0 mm. The pupil diameters were
obtained from the topographic measurements. Patients
were required to have normal keratometry and topography
(visually no suspect or form fruste keratoconus). Patients
who suffered from systemic illness, had a calculated corneal
bed thickness less than 300 mm after ablation, had preoper-
ative central corneal thickness of less than 470 mm, had
previous ocular surgery, or had abnormal corneal topog-
raphy were excluded from the study. Additional exclusion
criteria were clinically relevant lens opacity, a pupil offset
of 0.7 mm or more, and any signs of binocular vision anom-
alies at distance and near.
 PREOPERATIVE ASSESSMENT: A full ophthalmologic
examination was performed on all the patients prior to sur-
gery including manifest refraction, cycloplegic refraction,
slit-lamp microscopy of the anterior segment, handheld ul-
trasound pachymetry (Corneo-Gage Plus; Sonogage, Cleve-
land, Ohio, USA), dilated funduscopy, and Goldmann
intraocular pressure measurement. CDVA and uncorrected496 AMERICAN JOURNAL OFdistance visual acuity (UDVA) were assessed with Early
Treatment Diabetic Retinopathy Study (ETDRS) charts.
Near and intermediate acuity was assessed unaided and dis-
tance corrected (uncorrected near visual acuity [UNVA],
DCNVA, uncorrected intermediate visual acuity [UIVA],
and distance corrected intermediate visual acuity
[DCIVA]), with the Dutch version of the Radner Reading
Charts at 40 cm. All the tests were performed binocularly.
The selection of the distance and near eye was based on a
protocol described by Durrie.12
The corrected visual acuity was always assessed with trial
frames and not contact lenses. Binocular defocus curves
were measured (with both eyes corrected for distance, ie,
eliminating the effect of the micro-monovision compo-
nent) with induced lens blur from þ1.5 D to 4.0 D in
0.5 D randomized spherical steps, using distance ETDRS
charts with the letters randomized between presentations
and magnification effects being accounted for.13
Contrast sensitivity with and without glare was
measured using the Contrast Glare Tester CGT-1000
(Takagi Seiko Co Ltd, Nagano-Ken, Japan) at 6 target sizes
(6.3 degrees, 4.0 degrees, 2.5 degrees, 1.6 degrees, 1.0 de-
grees, and 0.7 degrees) after correcting the refractive errorSEPTEMBER 2015OPHTHALMOLOGY
FIGURE 4. Changes in binocular corrected distance visual
acuity (CDVA) at 1 year follow-up after treating with hybrid
bi-aspheric micro-monovision ablation profile for presbyopic
corneal treatments. (Top) Myopic patients: A loss of 2 Snellen
lines of CDVA was observed in 7% of myopic patients at 1 year
follow-up. (Bottom) Hyperopic patients: A loss of 2 Snellen
lines of CDVA was observed in 6% hyperopic patients at 1
year follow-up. W, M, and Y represent weeks, months, and
years, respectively.with spectacles. Log values of the contrast sensitivity scores
were used for statistical analysis.
Corneal and ocular aberrometry was performed with the
OPD Scan II (Nidek, Gamagori, Japan) over a 6 mm diam-
eter. Root mean square (RMS) higher-order aberrations,
Strehl ratio, and corneal asphericity were extracted.
Subjective patient-reported outcomes were assessed us-
ing 2 questionnaires: the Quality of Vision Questionnaire
and the Near Activity Visual Questionnaire. The Quality
of Vision Questionnaire was developed by McAlinden
and associates14,15 to assess symptoms such as glare, halos,
and starbursts with the use of simulation photographs.
Symptoms are scored based on their frequency, severity,
and bothersomeness. The questionnaire is valid for use
with spectacle wearers, contact lens wearers, and those
having had laser refractive surgery, intraocular refractive
surgery, or eye disease including cataract.16–18 The Near
Activity Visual Questionnaire was used to assess patient
satisfaction with near functional vision.19 For bothVOL. 160, NO. 3 HYBRID BI-ASPHERIC MICRO-MONOquestionnaires the raw response scores were converted to
a 0–100 Rasch scale, with higher scores indicating worse
quality of vision.
The Quality of Vision and Near Activity Visual Ques-
tionnaires were administered preoperatively and at
3 months, 6 months, and 1 year postoperatively. Patients
were instructed to answer the questionnaires at each
follow-up visit to recount their subjective impression in un-
aided bright and dim lighting conditions.
 SURGICAL PROCEDURE: All the treatments were pre-
pared using the SCHWIND PresbyMAX treatment
planning module in aspheric mode (SCHWIND eye-
tech-solutions GmbH and Co KG, Kleinostheim, Ger-
many). The devices used in this study bear the standards
of European conformity (Conformite´ Europe´ene or CE
marking) but are not approved by the US Food and Drug
Administration (FDA). The hybrid surgical technique
involved treating the dominant eye (also referred to as
the distant eye) more toward distance vision (target
refraction0.1 D) and the nondominant eye (also referred
to as the near eye) slightly toward near vision (target
refraction0.9 D) for achieving micro-monovision. Multi-
focality11,20–22 increases the range of intermediate vision
with a different depth of focus between the distant eye
(þ1.1 D) and the near eye (þ2.2 D).
For each treatment, the planning software calculated the
size of the optimal transition zone, depending on the preop-
erative refraction and optical treatment zone. Drops of
topical anaesthetic were instilled in the upper and lower
fornices. Flaps were made using Intralase iFS 150 KHz
femtosecond laser (AMO, Chicago, Illinois, USA) with a
100 mm nominal flap thickness.
Additional drops of topical anesthetics were instilled;
the lid margins and periocular region were disinfected using
diluted povidone. A sterile drape covering eye lashes and
face was used to isolate the surgical field. A lid speculum
was inserted to allow maximum exposure of the globe.
Proper alignment of the eye with the laser was achieved
with a 1050 Hz infrared eye tracker with simultaneous
limbus, pupil, and torsion tracking integrated into the laser
system and centered on the corneal vertex. The eye tracker
had a typical response time of 1.7 ms with a system total la-
tency time of 2.9 ms. The flap was lifted and the excimer
laser ablation was delivered to the stroma. Aspheric non-
wavefront-guided treatments were performed. The ablation
profile was centered on the corneal vertex determined by
the topographer (taking 70% of the pupil offset value),
which closely approximates the visual axis.23,24 Further,
the topographic keratometry readings at 3 mm diameter
were used for the compensation of the loss of efficiency
when ablating the cornea at non-normal incidences. Pa-
tients were requested to look at a pulsing green fixation
light throughout the ablation.
The flap was repositioned and the interface was irrigated
with balanced salt solution for removing any debris.497VISION PROFILES IN PRESBYOPIA
FIGURE 5. Spherical equivalent refraction and refractive astigmatism 1 year after treating with hybrid bi-aspheric micro-monovision
ablation profile for presbyopic corneal treatments. Myopic patients are presented in the left panels and hyperopic patients are
presented in the right panels. (Top) Postoperative spherical equivalent refraction. (Top left) In myopic patients, 100% of distance
eyes were within 0.5 diopter (D) of emmetropia while 67% of near eyes were within 0.6 D of micro-monovision target (L0.9 D).
(Top right) In hyperopic patients, 76% of distance eyes were within 0.5 D of emmetropia while 59% of near eyes were within
0.6 D of micro-monovision target (L0.9 D). (Bottom) Postoperative refractive astigmatism. (Bottom left) In myopic patients,
100% of distance eyes and 73%of near eyes were within 0.5D of astigmatism. (Bottom right) In hyperopic patients, 100%of distance
eyes and 59% of near eyes were within 0.5 D of astigmatism. DE[ distance eye; NE[ near eye.Patients received topical antibiotic drops 4 times a day for
1 week; corticosteroid drops 4 times a day tapering off in
1 week, and ocular lubricants as needed.
 POSTOPERATIVE EVALUATION: Patients were reviewed
at 6 weeks, 3 months, 6 months, and 1 year postoperatively.
All postoperative follow-up visits included measurement of
monocular and binocular UDVA, UNVA, UIVA, mani-
fest refraction, CDVA, DCNVA, DCIVA, and defocus
curves. The response to Quality of Vision and Near Activ-
ity Visual Questionnaires, topography and aberrometery,
and contrast sensitivity were recorded at every follow-up
visit except 6 weeks postoperatively.
 STATISTICAL ANALYSIS: Data were assessed for
normality using the Shapiro-Wilk test. Analysis of variance
and t tests were performed on normally distributed data and
Friedman tests and post hoc Wilcoxon signed rank tests
when the data were not normally distributed.
Distance visual acuity was evaluated in logMAR but
converted to equivalent Snellen fractions for reporting
comparability. Similarly, near visual acuity was evaluated498 AMERICAN JOURNAL OFin logRAD but converted to Jaeger scale for reporting
comparability. Manifest refraction was used for preopera-
tive to postoperative comparison. Uncorrected and
corrected visual acuity, contrast sensitivity, spherical
equivalent refraction, and refractive astigmatism were indi-
vidually analyzed for myopic and hyperopic patients.RESULTS
THE MEAN OPTICAL TREATMENT ZONE DIAMETER WAS 6.58
6 0.26 mm (6.0–7.0 mm, median 6.5 mm). The total abla-
tion zone ranged from 6.8 mm to 8.9 mm.
 EFFICACY: The distribution of binocular UDVA, UIVA,
and UNVA are presented in Figure 1. At 1 year follow-up,
93% (13 out of 14) of myopic patients and 94% (15 out of
16) of hyperopic patients achieved 20/20 or better binoc-
ular UDVA; 100% (14 out of 14) of myopic patients and
94% (15 out of 16) of hyperopic patients achieved Jaeger
level J2 or better UIVA; while 93% (13 out of 14) ofSEPTEMBER 2015OPHTHALMOLOGY
FIGURE 6. Mean spherical equivalent refraction assessed
preoperatively and at 1 year follow-up after treating with hybrid
bi-aspheric micro-monovision ablation profile for presbyopic
corneal treatments. (Top) Myopic patients. (Bottom) Hyper-
opic patients. Refractive stability was achieved for both distance
(DE) and near eye (NE) in myopic and hyperopic patients, from
6 weeks postoperatively. W, M, and Y represent weeks, months,
and years, respectively.
FIGURE 7. The relationship between laser setting spherical
equivalent refraction and the achieved spherical equivalent
refraction 1 year after treating with hybrid bi-aspheric micro-
monovision ablation profile for presbyopic corneal treatments.
A linear trend can be observed between the attempted and
achieved refraction in our cohort (R2[ 0.9754).
FIGURE 8. Quality of Vision (QoV) Questionnaire scores
assessing symptoms based on their frequency, severity, and
bothersomeness, on each follow-up visit after presbyLASIK
treatment. The raw response scores were converted to a
0–100 Rasch scale with higher scores indicating worse quality
of vision. A minor decline is observed in the Rasch scores post-
operatively compared to the corrected preoperative scores. M
and Y represent months and years, respectively.
VOL. 160, NO. 3 HYBRID BI-ASPHERIC MICRO-MONOmyopic patients and 88% (14 out of 16) of hyperopic pa-
tients achieved Jaeger level J2 or better UNVA.
Changes in contrast sensitivity scores were assessed with
and without the disability glare (Figure 2). At 3 and 6months
follow-up, the contrast sensitivity scores remained similar to
the respective preoperative scores in both tests (with and
without the disability glare), but improved, respectively, at
the 1 year follow up (P < .005 at all sizes).
 SAFETY: The change in binocular DCIVA and DCNVA
is presented in Figure 3. At 1 year follow-up, 85% (11 out of
13) of myopic patients and 94% (15 out of 16) of hyperopic
patients achieved a Jaeger level J2 or better binocular
DCIVA, while 57% (8 out of 14) of myopic patients and
63% (10 out of 16) of hyperopic patients achieved a Jaeger
level J4 or better binocular DCNVA. A loss of 2 Snellen
lines of binocular CDVA (Figure 4) was observed in 7%
(1 out of 14) of myopic patients and 6% (1 out of 16) of
hyperopic patients at 1 year follow-up.
 ACCURACY: For myopic and hyperopic patients, a good
separation was observed between the dominant and nondom-
inant eye for refractive deviation from target spherical equiv-
alent refraction and astigmatism (Figure 5). In myopic
patients, 100% (15 out of 15) of distance eyes were within
0.5 D of emmetropia while 67% (10 out of 15) of near eyes
were within 0.6 D of micro-monovision target (0.9 D); in
hyperopic patients, 76% (13 out of 17) of distance eyes were
within 0.5 D of emmetropia while 59% (10 out of 17) of
near eyes were within 0.6 D of micro-monovision target
(0.9D). Formyopicpatients, 100%(15outof 15)of distance
eyes and 73% (11 out of 15) of near eyes were within 0.5 D of
astigmatism; in hyperopic patients, 100% (17 out of 17) of dis-
tance eyes and 59% (10 out of 17) of near eyes werewithin 0.5499VISION PROFILES IN PRESBYOPIA
FIGURE 9. Near Activity Visual Questionnaire (NAVQ)
scores assessing patient satisfaction with near functional vision
and overall satisfaction level, preoperatively and at the last post-
operative visit after treating with hybrid bi-aspheric micro-
monovision ablation profile for presbyopic corneal treatments.
The raw response scores were converted to a 0–100 Rasch scale
with higher scores indicating worse quality of vision. NAVQ
improved from little to very high satisfaction level, with an
improvement in Rasch scores. ‘‘Last’’ represents the Rasch
scores at the last follow-up (at 6 months or 1 year postopera-
tively).
FIGURE 10. Change in corneal asphericity (Q value) at 3 mm
diameter, Strehl ratio (Strehl), root mean square (RMS) of
higher-order aberrations (at 6 mm diameter), corneal and ocular
spherical aberrations (Corn SA and OC SA, respectively, at
6 mm diameter) preoperatively and at 1 year follow-up after
treating with hybrid bi-aspheric micro-monovision ablation
profile for presbyopic corneal treatments. M and Y represent
months and years, respectively. One year postoperatively, the
Strehl ratio reduced by wL4% ± 14% and the corneal and
ocular spherical aberrations (at 6 mm diameter) decreased
by L0.38 ± 0.33 mm and L0.28 ± 0.35 mm, respectively,
with an increase in RMS higher-order aberrations (at 6 mm
diameter) by 0.15 ± 0.24 mm. All these metrics indicated
good stability from 3 months onward.
FIGURE 11. Binocular defocus curves from uncorrected vision
asymmetrically to longer (D1.5 diopter [D]) and shorter vergen-
ces (L4.0 D), assessed preoperatively and at 1 year follow-up
after treating with hybrid bi-aspheric micro-monovision ablation
profile for presbyopic corneal treatments. The error bars repre-
sent the upper and lower 95% confidence limits of the mean of
measurements, preoperatively. The upper and lower envelope
represents, respectively, the maximum and minimum values of
the confidence limits of postoperative measurements (irrespec-
tive of the follow-up time) with respect to vergence. W, M, and
Y represent weeks, months, and years, respectively.
FIGURE 12. Change in defocus curves with respect to
vergence, assessed preoperatively and at last follow-up after
treating with hybrid bi-aspheric micro-monovision ablation pro-
file for presbyopic corneal treatments. At 1 year follow-up, a loss
of half a logMAR was observed at best focus for distance, with
no change for intermediate vergence (L1.25 diopter [D]) and
a mean gain of 2 lines for near vergence (L3 D).
500 AMERICAN JOURNAL OFD of astigmatism. Refractive stability was achieved for both
dominant (DE) and non-dominant eye (NE) in myopic and
hyperopic patients, from 6 weeks postoperatively (Figure 6).
A nearly linear (coefficient of determination r2 ¼ 0.97, P <
.00001) relationship between the laser attempted and
achieved spherical equivalent refraction was observed
(Figure 7).SEPTEMBER 2015OPHTHALMOLOGY
FIGURE 13. Change in binocular uncorrected distance visual acuity (UDVA) and spherical equivalent refraction after a secondary
treatment (in 12 eyes, 11 patients), to improve distance (9 eyes) or near (3 eyes) outcomes in eyes that underwent an initial treatment
with hybrid bi-aspheric micro-monovision ablation profile for presbyopic corneal treatments. All retreatments were performed after
the 6-month follow-up. All follow-up times presented here are from the initial treatments (ie, up to 6 months post-retreatment).
Myopic patients are presented in the left panels and hyperopic patients are presented in the right panels. (Top left) Eighty-three
percent of myopic patients achieved a 20/20 or better binocular UDVA at 1 year follow-up, compared to only 20% at 6 months
follow-up; (Top right) 100% of hyperopic patients achieved a 20/20 or better binocular UDVA at 1 year follow-up, compared to
only 60% at 6 months follow-up; (Bottom) Mean spherical equivalent refraction at 1 year follow-up in distance eye was 0.1 diopter
(D) for myopic patients (left) and L0.3 D for hyperopic eyes (right), whereas for near eye it was L1.3 D for both myopic and
hyperopic patients. SUBJECTIVE RATING: Quality of Vision scores assessing
symptoms based on their frequency, severity, and bother-
someness are presented in Figure 8. Compared to the
corrected preoperative scores, the Quality of Vision score
worsened postoperatively (P ¼ .02), mainly with an in-
crease in patients seeing haloes (P ¼ .002), blurred vision
(P ¼ .02), and double vision (P ¼ .01).
Near Activity Visual Questionnaire (NAVQ) scores
assessing patient satisfaction with near functional vision
and overall satisfaction are presented in Figure 9. The
Near Activity Visual Questionnaire scores improved
from little satisfaction to very high satisfaction level (P
< .00001), with an improvement in Rasch scores (P <
.0001). Stability was observed in Near Activity Visual
Questionnaire scores from 3 months follow-up time.
 ABERRATIONS: Change in corneal asphericity (Q value)
at 3 mm diameter, Strehl ratio, RMS of higher-order aber-
rations (at 6 mm diameter), and corneal and ocular spher-
ical aberrations are presented in Figure 10. Asphericity wasVOL. 160, NO. 3 HYBRID BI-ASPHERIC MICRO-MONOmore prolate after surgery, indicating a central myopia
(within 3 mm diameter, P< .00001). Compared to the pre-
operative status, 1 year postoperatively the Strehl ratio
reduced by w4% 6 14% (P ¼ .00007) and the corneal
and ocular spherical aberrations (at 6 mm diameter)
decreased by 0.38 6 0.33 mm and 0.28 6 0.35 mm,
respectively (P < .00001), with an increase in RMS
higher-order aberrations (at 6 mm diameter) by 0.15 6
0.24 mm (P ¼ .00002). All these metrics indicated good
stability from 3 months onward.
Binocular defocus curves and the change between defo-
cus curves (preoperatively and at 1 year follow-up) are
presented in Figures 11 and 12, respectively. Defocus curves
indicate stability from 6 weeks follow-up. The difference in
defocus curves shows a decrease of 0.05 logMAR at best
focus (0.35 6 0.57 lines, P ¼ .0009), with no change
for intermediate vergence (1.00 D and 1.50 D) and a
mean gain of 2 lines for near vergence (2.00 D and closer,
P ¼ .00400) at 1 year follow-up. A slightly better distance
vision was observed preoperatively, but the near and501VISION PROFILES IN PRESBYOPIA
TABLE. A Comparison of Clinical Outcomes Using Different Techniques for Laser Presbyopia Corrections
Study n Follow-up Group/Subgroup UDVA 20/20 or Better UNVA J2 or Better
CDVA Loss 2 or
More Lines Ret Rev
PresbyLASIK
Alio et al8 50 6 M Presb 64% 72% (20/40 or
better)
14% 12% -
Luger et al11 66 1 Y Hyp and myo
with/without
astig
48% 94% 3% - -
Luger et al20 48 3 M Hyp and myo
with/without
astig
25% 50% - 0% 0%
Iribarne et al21 50 6 M Hyp and myo
with/without
astig
41% 91% 5% - -
Baudu et al22 716 6 M Myo 43% 98% 26% 19% (overall) 1% (overall)
Hyp 45% 90% 25%
Monovision
Wright et al3 42 7 M (3–15) Myo presb
treated with
PRK induced
monovision
76.2% 100% (20/30 or
better)
- 26.2% -
32 11 M (3–17) Emm treated with
PRK
62.5% 25% (20/30 or
better)
- 37.5% -
Alarco´n et al28 50 3 M 90% 90% (J1 or better) - 12% -
Conductive keratoplasty
Stahl29 10 1 Y 1 Y follow up 89% (20/20
and J1)
89% - 0% (overall) 0% (overall)
9 3 Y 3 Y follow up 22% (20/20
and J1)
33% -
Supracor
Ryan et al30 46 6 M Hyp 48% 73.9% (J5 or
better)
4% 21.7% -
Intracor
Holzer et al31 25 3 M 48% 8% (20/20 or
better)
8% - -
Intracorneal inlay
Yilmaz et al32 22 4 Y Emm or post
LASIK presb
73% 96% (J3 or better) 5% 22.7% (cataract
extraction)
18.2%
Seyeddain
et al26
32 2 Y Emm presb 74% 65.6% (J1 or
better)
6% 6.3% 0%
Tomita et al33 223 6 M Presb patients
with previous
LASIK
100% 77% 0% - -
Multifocal IOL
McAlindin et al2 44 3 M - 68.2% - 0% 13.6% 0%
Biaspheric cornea modulation
Uthoff et al34 20 6 M Emm 80% (0.1 logMAR) 40% (0.1 logRAD) 10% 6.6%–10% (may
require overall)20 6 M Hyp 100% (0.1
logMAR)
30% (0.1 logRAD) 10%
20 6 M Myo 70% (0.1 logMAR) 60% (0.1 logRAD) 20%
Presented study
Current 64 1 Y 93% 90% 7% 19% 3%
Astig ¼ astigmatism; CDVA ¼ corrected distance visual acuity; Emm ¼ emmetropia; Hyp ¼ hyperopia; IOL ¼ intraocular lens; M ¼months;
Myo ¼ myopia; n ¼ number of eyes; Presb ¼ presbyopia; Ret ¼ retreatments; Rev ¼ reversals; UDVA ¼ uncorrected distance visual acuity;
UNVA ¼ uncorrected near visual acuity; Y ¼ year.
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intermediate vision (at 2.00 D//50 cm and 2.50 D//40 cm)
improved postoperatively.
 RETREATMENTS: Secondary treatment was performed in
12 eyes (11 patients: 19% from the 64 eyes; 7 eyes in Myopic
group [of 6 patients] and 5 eyes in Hyperopic group [of 5 pa-
tients]) to improve distance (9 eyes) or near (3 eyes) out-
comes. The secondary treatments were performed using a
non-wavefront-guided aspheric treatment to tune distance
refraction to the desired value. All retreatments were
performed after at least 6 months follow-up after the initial
treatment. Figure 13 presents the preoperative CDVA (pre-
PresbyMAX) and the postoperative UDVA (pre- and post-
retreatment) and spherical equivalent refraction in the eyes
that underwent a secondary treatment. At 1 year follow-up
from the initial treatment (ie, up to 6 months post-
retreatment), 83% (5 out of 6) of myopic patients and
100% (5 out of 5) of hyperopic patients undergoing secondary
treatment achieved a 20/20 or better binocular UDVA.
Compared to the outcomes at 6 months follow-up pre-
retreatment, significant improvements were observed post-
retreatment (only 20% [1 out of 5] of myopic and 60% [3
out of 5] of hyperopic patients achieved 20/20 or better binoc-
ular UDVA 6 months postoperatively after the initial treat-
ment). Binocular UIVA and UNVA remained relatively
stable in these eyes through the postoperative follow-ups.
Two eyes (3% from the 64 eyes) underwent a partial
Presby reversal treatment to reduce the effects of the pri-
mary treatment, owing to the patient’s perceived intoler-
ance (mainly loss of CDVA) to the induced
multifocality. The details about the reversal of this tech-
nique and corresponding aberrations and topography
changes have been published elsewhere.25DISCUSSION
THIS CONSECUTIVE CASE SERIES ANALYZED THE EFFICACY
and safety of presbyopic treatments using a hybrid bi-
aspheric micro-monovision ablation profile. This tech-
nique was expected to combine the benefits of multifocal
ablations and micro-monovision with enhanced depth of
focus and a wider range of intermediate vision. Our inde-
pendent analysis of myopic and hyperopic patients revealed
very comparable long-term results after the treatment. The
binocular vision was expected to improve overall, with the
nondominant eye imparting an improvement in Near Ac-
tivity Visual Questionnaire scores and the dominant eye
imparting an improvement in Quality of Vision scores.
Most of the outcome measures showed significant improve-
ment compared to the preoperative status. The improve-
ment in corrected and uncorrected distance and near
visual acuity was significant postoperatively. Improvements
in refraction and visual acuity were also seen in patients un-
dergoing secondary treatments. In addition, analyzing theVOL. 160, NO. 3 HYBRID BI-ASPHERIC MICRO-MONONear Activity Visual Questionnaire responses revealed
an improvement in all the topics and the Rasch scores indi-
cated improvements from little (preoperative) to high
(postoperative) satisfaction. Although it would be inter-
esting to know the profile of the defocus curves monocu-
larly for the presbyopic eyes, this was not possible owing
to the retrospective nature of this study. However, the defo-
cus curves with both eyes corrected for distance (ie, elimi-
nating the effect of the micro-monovision component)
revealed a loss of half a Snellen line at the best focus for dis-
tance but a gain of 2 lines at the near vergence. Monocu-
larly, it would be expected that the defocus curves would
be shallower, with separation between the dominant and
nondominant eye. The metric area under the defocus
curves demonstrates a slight drop at distance vision postop-
eratively, but not a gain at near or intermediate vision. This
could be due to the curves crossing at near (2.00 D
to4.00 D) and intermediate (0.50 D to2.00 D) vision
boundary and missing data points in this range.
Corneal topography and aberrometery revealed a
decrease in corneal and ocular spherical aberrations, associ-
ated with an increase in the RMS higher-order aberrations.
Furthermore, Quality of Vision responses revealed minor
decline in terms of blurred vision, haloes, and double vision
postoperatively compared to the patient responses preoper-
atively (using correction glasses). Stability in the Near Ac-
tivity Visual Questionnaire rating and refraction was
reached after 3 months and 6 weeks postoperatively. The
presented clinical outcomes are based on 1 year of clinical
follow-up, which is considered adequate in refractive sur-
gery. However, presbyopia increases with age. Therefore,
longer follow-up could shed light on the durability of per-
formance during further degradation of accommodation.
As a recommendation from the manufacturer of the laser
system, patients were required to have pupil diameters
smaller than 3.0 mm in photopic (for effectively using
the central near disk of the profile) and larger than
4.5 mm in mesopic light conditions (for getting enough
light in the distance focus using the pericentral distance
annulus of the profile; however, pupil diameters were ob-
tained from the topography, and eyes with pupil diameter
smaller than 3.0 mm in photopic conditions are currently
included for surgery by the clinic.
Many clinical studies have evaluated various surgical
techniques to treat presbyopia; however, the current devel-
opments throughout the corneal presbyopic correction
spectrum indicate a converging trend toward hybrid tech-
niques. These hybrid modifications include Supracor
(TECHNOLAS Perfect Vision GmbH), PresbyMAX
(reduced multifocality in distance eye combined with full
multifocality and monovision in the near eye), Intracor
(full correction in distance eye combined with Intracor
multifocality and monovision in the near eye), KAMRA
(AcuFocus, Inc) (full correction in distance eye combined
with pinhole-based extended depth of focus and monovi-
sion in the near eye), Presbyond (Carl Zeiss Meditec AG)503VISION PROFILES IN PRESBYOPIA
laser blended vision (moderate multifocality in both eyes
combined with monovision in the near eye), and refractive
corneal inlays (eg, raindrop from ReVision Optics, USA).
A brief summary and comparison of the clinical studies
with different methods to treat presbyopia is presented in
the Table, although intermediate visual acuity is not
included owing to the unavailability of this metric in
most studies. However, Seyeddain and associates26 reported
in their cohort 71.9% of treatments achieving 20/20 or bet-
ter UIVA compared to the 63% reported in our cohort.
Methods depending only on the depth of focus might face
difficulty to create more than 1.5 D of near vision indepen-
dence. In contrast, with the models based on multifocal ab-
lations one can gain a higher near vision independence.
Since presbyopia increases with age, a wide range of near
vision shall be an asset in such cases. In addition, the differ-
ence in the depth of focus between the near and far eye pro-
vides the patient with a wider binocular range of focus for an
enhanced intermediate vision.504 AMERICAN JOURNAL OFThe depth of focus acts as a useful marker; however, some
studies consider acuity at a typical near vision distance as a
more suitable metric that is closely related to patients’ real
expectations and concerns.27 Our analysis and results indi-
cate significant success in presbyopic treatments using the
hybrid bi-aspheric micro-monovision ablation profiles. We
evaluated the subjective perception of patients for distance
(Quality of Vision) and near visual quality (Near Activity
Visual Questionnaire scores) and found significant im-
provements in the Near Activity Visual Questionnaire
scores with improved uncorrected and corrected near and
distance visual acuity and contrast sensitivity. Presbyopic
treatment using a hybrid bi-aspheric micro-monovision
ablation profile is safe and efficacious. The postoperative
outcomes indicate improvements in binocular vision at
far, intermediate, and near distances with improved
contrast sensitivity. A 19% retreatment rate should be
considered to increase satisfaction levels, besides a 3%
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